皮膚科治療薬市場：薬剤クラス別、用途別-2025～2030年の世界予測

皮膚科治療薬市場は、2023年に569億9,000万米ドルと評価され、2024年には626億8,000万米ドルに達すると予測され、CAGR 10.38％で成長し、2030年には1,137億9,000万米ドルに達すると予測されています。

皮膚科治療薬市場は、にきびや乾癬のような一般的な症状からメラノーマのような重篤な疾患まで、皮膚関連の健康問題に対処することを目的とした幅広い治療と製品を包含しています。このセグメントは、皮膚疾患の増加、環境の変化やライフスタイル要因によって拍車がかかったスキンケアや治療オプションに対する意識の高まりによって必要とされています。皮膚科治療の用途には、局所治療、全身治療、生物製剤や遺伝子治療のような先進治療が含まれ、医療センター、皮膚科クリニック、研究機関を主要エンドユーザーとしています。主要成長要因としては、医療支出の増加、技術革新の進展、美容強化処置に対する強い需要などが挙げられます。個別化医療と遺伝子研究の増加は、希少かつ重度の皮膚疾患を対象とする潜在的な機会を開くものであり、このセグメントへの投資は大きなリターンをもたらす可能性があります。こうした機会を捉えるには、企業はアンメットニーズのある新興国市場に注目し、革新的な医薬品開発技術に投資すべきです。しかし、研究開発費の高騰、厳しい規制環境、ジェネリック医薬品との競合といった課題もあり、限界があります。企業はまた、特許の崖や新規治療に関連する潜在的な副作用を克服しなければならないです。技術革新が最も期待されるセグメントには、生物学的治療、遠隔皮膚科学の進歩、診断と治療の個別化における人工知能などがあります。市場はダイナミックで、高い競争と、技術の進歩や消費者の期待に促された急速な変化を特徴としています。治療効果と美容効果を併せ持つ多機能医薬品に焦点を当てた研究開発は、皮膚科的な健康と美容の両方の要望に応える製品への需要に合致し、成長の道筋を示すものです。競合を維持しようとする企業は、ポートフォリオと市場リーチを強化するために、戦略的提携や買収も検討すべきです。こうした力学を巧みに操ることで、皮膚科治療薬市場の利害関係者はイノベーションとアンメット・クリニカル・ニーズを活用し、ビジネスの成長に効果的に拍車をかけることができます。

市場力学：急速に進化する皮膚科治療市場の主要市場洞察を公開

皮膚科治療薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネス機会の獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 皮膚疾患の罹患率の増加
  • 医療費の増加と皮膚疾患に対する意識の高まり
  • ホメオパシー皮膚科治療に対する需要増加
• 市場抑制要因
  • 皮膚科治療のコストが比較的高い
• 市場機会
  • 皮膚がんの次世代治療の開発
  • 皮膚科治療の研究開発と技術革新
• 市場課題
  • 特定クラスの治療の副作用

ポーターのファイブフォース：皮膚科治療薬市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：皮膚科治療薬市場における外部からの影響の把握

外部マクロ環境要因は、皮膚科治療薬市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：皮膚科治療薬市場における競合情勢の把握

皮膚科治療薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：皮膚科治療薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、皮膚科治療薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：皮膚科治療薬市場における成功への道筋を描く

皮膚科治療薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 市場促進要因
    • 皮膚疾患の罹患率の増加
    • 医療費の増加と皮膚疾患に対する意識の高まり
    • ホメオパシー皮膚科治療の需要増加
  • 抑制要因
    • 皮膚科治療のコストが比較的高い
  • 市場機会
    • 皮膚がんの次世代治療の開発
    • 皮膚科医療の研究開発と技術革新
  • 市場課題
    • 特定クラスの治療の副作用
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 皮膚科治療薬市場：薬剤クラス別

• イントロダクション
• ニキビ予防
• 抗感染薬
• カルシニューリン阻害剤
• コルチコステロイド
• レチノイド

第7章 皮膚科治療薬市場：用途別

• イントロダクション
• 脱毛症
• アトピー性皮膚炎
• ヘルペス
• 乾癬
• 酒さ様皮膚炎

第8章 南北アメリカの皮膚科治療薬市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋の皮膚科治療薬市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの皮膚科治療薬市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Aclaris Therapeutics Inc.
• Allergan PLC by AbbVie Inc.
• Almirall, LLC
• Amgen Inc.
• AstraZeneca PLC
• Bausch Health Companies Inc.
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• Galderma Laboratories, L.P.
• GlaxoSmithKline PLC
• Johnson & Johnson Services Inc.
• Leo Pharma A/S
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• Sun Pharmaceutical Industries, Inc.

LIST OF FIGURES

• FIGURE 1. DERMATOLOGICAL THERAPEUTICS MARKET RESEARCH PROCESS
• FIGURE 2. DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. DERMATOLOGICAL THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. DERMATOLOGICAL THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DERMATOLOGICAL THERAPEUTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DERMATOLOGICAL THERAPEUTICS MARKET DYNAMICS
• TABLE 7. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY ANTI-ACNE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY ANTI-INFECTIVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY RETINOIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY ALOPECIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY ATOPIC DERMATITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY HERPES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY PSORIASIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY ROSACEA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. CANADA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 27. CANADA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. MEXICO DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 29. MEXICO DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. UNITED STATES DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 31. UNITED STATES DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. UNITED STATES DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 33. ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 34. ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 36. AUSTRALIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 37. AUSTRALIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. CHINA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 39. CHINA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. INDIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 41. INDIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. INDONESIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 43. INDONESIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. JAPAN DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 45. JAPAN DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. MALAYSIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 47. MALAYSIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. PHILIPPINES DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 49. PHILIPPINES DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. SINGAPORE DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 51. SINGAPORE DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. SOUTH KOREA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 53. SOUTH KOREA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. TAIWAN DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 55. TAIWAN DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. THAILAND DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 57. THAILAND DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. VIETNAM DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 59. VIETNAM DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 61. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 63. DENMARK DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 64. DENMARK DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. EGYPT DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 66. EGYPT DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. FINLAND DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 68. FINLAND DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. FRANCE DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 70. FRANCE DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. GERMANY DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 72. GERMANY DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. ISRAEL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 74. ISRAEL DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. ITALY DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 76. ITALY DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. NETHERLANDS DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 78. NETHERLANDS DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. NIGERIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 80. NIGERIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. NORWAY DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 82. NORWAY DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. POLAND DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 84. POLAND DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. QATAR DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 86. QATAR DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. RUSSIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 88. RUSSIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. SAUDI ARABIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 90. SAUDI ARABIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH AFRICA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 92. SOUTH AFRICA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. SPAIN DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 94. SPAIN DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. SWEDEN DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 96. SWEDEN DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. SWITZERLAND DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 98. SWITZERLAND DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. TURKEY DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 100. TURKEY DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. UNITED ARAB EMIRATES DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 102. UNITED ARAB EMIRATES DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. UNITED KINGDOM DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
• TABLE 104. UNITED KINGDOM DERMATOLOGICAL THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. DERMATOLOGICAL THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 106. DERMATOLOGICAL THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

The Dermatological Therapeutics Market was valued at USD 56.99 billion in 2023, expected to reach USD 62.68 billion in 2024, and is projected to grow at a CAGR of 10.38%, to USD 113.79 billion by 2030.

The dermatological therapeutics market encompasses a broad spectrum of treatments and products aimed at addressing skin-related health issues, ranging from common conditions like acne and psoriasis to severe diseases such as melanoma. This sector is necessitated by rising skin disorders and a growing awareness of skincare and treatment options, spurred by environmental changes and lifestyle factors. Applications of dermatological therapeutics include topical treatments, systemic medications, and advanced therapies like biologics and gene therapies, catering to medical centers, dermatology clinics, and research institutions as primary end-users. Key growth influencers include increased healthcare spending, advancing technological innovations, and a strong demand for aesthetic enhancement procedures. The rise in personalized medicine and genetic research opens potential opportunities for targeting rare and severe dermatological conditions; investment in this area could yield substantial returns. To seize these opportunities, companies should focus on emerging markets with unmet needs and invest in innovative drug development technologies. However, challenges such as high R&D costs, stringent regulatory environments, and competition from generic products pose limitations. Companies must also navigate patent cliffs and potential side effects associated with novel therapies. The most promising areas for innovation include biologic therapeutics, teledermatology advancements, and artificial intelligence in diagnosis and treatment personalization. The market is dynamic, characterized by high competition and rapid changes prompted by technological advancements and consumer expectations. Research and development focused on multifunctional drugs that combine therapeutic and cosmeceutical benefits represent a growth avenue, aligning with demand for products that cater to both dermatological health and aesthetic desires. Companies looking to stay competitive should also consider strategic collaborations or acquisitions to enhance their portfolios and market reach. By navigating these dynamics thoughtfully, stakeholders in the dermatological therapeutics market can leverage innovation and unmet clinical needs to spur business growth effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Dermatological Therapeutics Market

The Dermatological Therapeutics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalences of the skin disorders
  • Increasing healthcare expenditure and growing awareness about skin diseases
  • Rising demand for homeopathy dermatology therapeutics
• Market Restraints
  • Relatively high cost of the dermatology therapeutics
• Market Opportunities
  • Development of next-generation therapeutics for skin cancer
  • Medical dermatology therapeutic R&D and technical innovation
• Market Challenges
  • Side effects for certain classes of therapeutic drugs

Porter's Five Forces: A Strategic Tool for Navigating the Dermatological Therapeutics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Dermatological Therapeutics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Dermatological Therapeutics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Dermatological Therapeutics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Dermatological Therapeutics Market

A detailed market share analysis in the Dermatological Therapeutics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Dermatological Therapeutics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Dermatological Therapeutics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Dermatological Therapeutics Market

A strategic analysis of the Dermatological Therapeutics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Dermatological Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Aclaris Therapeutics Inc., Allergan PLC by AbbVie Inc., Almirall, LLC, Amgen Inc., AstraZeneca PLC, Bausch Health Companies Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Galderma Laboratories, L.P., GlaxoSmithKline PLC, Johnson & Johnson Services Inc., Leo Pharma A/S, Merck & Co., Inc., Novartis AG, Pfizer Inc., and Sun Pharmaceutical Industries, Inc..

Market Segmentation & Coverage

This research report categorizes the Dermatological Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Drug Class, market is studied across Anti-Acne, Anti-Infectives, Calcineurin Inhibitors, Corticosteroids, and Retinoids.
• Based on Application, market is studied across Alopecia, Atopic Dermatitis, Herpes, Psoriasis, and Rosacea.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalences of the skin disorders
    • 5.1.1.2. Increasing healthcare expenditure and growing awareness about skin diseases
    • 5.1.1.3. Rising demand for homeopathy dermatology therapeutics
  • 5.1.2. Restraints
    • 5.1.2.1. Relatively high cost of the dermatology therapeutics
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of next-generation therapeutics for skin cancer
    • 5.1.3.2. Medical dermatology therapeutic R&D and technical innovation
  • 5.1.4. Challenges
    • 5.1.4.1. Side effects for certain classes of therapeutic drugs
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Dermatological Therapeutics Market, by Drug Class

• 6.1. Introduction
• 6.2. Anti-Acne
• 6.3. Anti-Infectives
• 6.4. Calcineurin Inhibitors
• 6.5. Corticosteroids
• 6.6. Retinoids

7. Dermatological Therapeutics Market, by Application

• 7.1. Introduction
• 7.2. Alopecia
• 7.3. Atopic Dermatitis
• 7.4. Herpes
• 7.5. Psoriasis
• 7.6. Rosacea

8. Americas Dermatological Therapeutics Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Dermatological Therapeutics Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Dermatological Therapeutics Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Aclaris Therapeutics Inc.
• 2. Allergan PLC by AbbVie Inc.
• 3. Almirall, LLC
• 4. Amgen Inc.
• 5. AstraZeneca PLC
• 6. Bausch Health Companies Inc.
• 7. Bristol-Myers Squibb Company
• 8. Eli Lilly and Company
• 9. Galderma Laboratories, L.P.
• 10. GlaxoSmithKline PLC
• 11. Johnson & Johnson Services Inc.
• 12. Leo Pharma A/S
• 13. Merck & Co., Inc.
• 14. Novartis AG
• 15. Pfizer Inc.
• 16. Sun Pharmaceutical Industries, Inc.